The central purpose of CRAVAT is to provide information for people with epithelioid hemangioendothelioma (EHE), and to enable basic research that can lead to better treatments and outcomes.
We seek to gather, organize and disseminate to members of the public, including patients and physicians, scientific data about the genesis, progress and treatment of EHE. This cancer cause sickness and death in people both in the United States and around the world. CRAVAT hopes to offer support to those affected with these tumors, raise awareness among medical researchers and the public in general about EHE, fund basic research into the biology of EHE, and to help develop treatments. Of course, finding a cure is paramount in our aim, that is the purpose of our supporting cutting edge basic research. We also want to be your source to learn as much as you can about EHE and to keep up-to-date with all that’s new in the field.